Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection
This study has been completed.
Sponsor:
Bavarian Nordic
Information provided by:
Bavarian Nordic
ClinicalTrials.gov Identifier:
NCT00386633
First received: October 9, 2006
Last updated: December 21, 2007
Last verified: December 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | November 2007 |
| Estimated Primary Completion Date: | No date given |